Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
0.6900
+0.0340 (5.18%)
At close: Apr 2, 2025, 4:00 PM
0.6712
-0.0188 (-2.72%)
After-hours: Apr 2, 2025, 7:09 PM EDT

Adial Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
56265724
Upgrade
Market Cap Growth
185.59%185.59%-60.76%-89.79%131.14%-1.60%
Upgrade
Enterprise Value
11205017
Upgrade
Last Close Price
0.661.011.865.3867.5042.50
Upgrade
PB Ratio
1.041.590.561.7616.126.14
Upgrade
P/TBV Ratio
1.591.590.561.7720.216.15
Upgrade
Debt / Equity Ratio
----0.07-
Upgrade
Quick Ratio
3.843.844.332.242.232.92
Upgrade
Current Ratio
4.164.164.902.672.373.41
Upgrade
Return on Equity (ROE)
-323.80%-323.80%-190.27%-318.27%-518.38%-195.80%
Upgrade
Return on Assets (ROA)
-105.88%-105.88%-82.24%-102.77%-170.58%-103.71%
Upgrade
Return on Capital (ROIC)
-127.04%-127.04%-116.98%-192.78%-285.36%-122.77%
Upgrade
Earnings Yield
-306.00%-203.98%-226.15%-220.51%-34.34%-44.52%
Upgrade
FCF Yield
-160.50%-106.99%-300.46%-193.74%-21.24%-31.20%
Upgrade
Buyback Yield / Dilution
-240.54%-240.54%-42.25%-34.69%-49.15%-26.50%
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q